NCT03522649 2019-06-18A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer1Globe Biomedical Co., Ltd.Phase 3 Unknown668 enrolled